American Journal of Ophthalmology
Volume 148, Issue 1 , Pages 43-58.e1, July 2009

A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study

Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida

Accepted 27 January 2009. published online 20 April 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 See accompanying Editorial on page 1.

 Anne Fung is currently at the Pacific Eye Associates, California Pacific Medical Center, San Francisco, California. Stephen Michels is currently at the Department of Ophthalmology, University Hospital Zürich, Zürich, Switzerland.

PII: S0002-9394(09)00102-0

doi:10.1016/j.ajo.2009.01.024

Refers to article:

  • The As-Needed Treatment Strategy for Choroidal Neovascularization: A Feedback-Based Treatment System

    Richard F. Spaide
    American Journal of Ophthalmology July 2009 (Vol. 148, Issue 1, Pages 1-3)

American Journal of Ophthalmology
Volume 148, Issue 1 , Pages 43-58.e1, July 2009

Article Tools

* Image Usage & Resolution